# Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

> **NCT00947011** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 12 (actual)

## Conditions studied

- Glucose Homeostasis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Januvia

## Key facts

- **NCT ID:** NCT00947011
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** PI left JHU
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947011, "Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00947011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*